Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Simon Fraser University

$44,000.00

Multixenobiotic resistance mechanisms: function and relevance of P-glycoprotein (ABCB1) in teleosts

EF 2013-14

Résumé
One basic cellular strategy underlying resistance to foreign chemicals is to reduce intracellular concentrations. One of the most intriguing defense strategies developed is the activity of the multixenobiotic resistance mechanism (MXR), analogous to the multidrug resistant (MDR) mechanism found in mammalian cell lines and tumors of human patients resistant to chemotherapeutic drugs. MXR activity is mediated by the expression of a variety of transmembrane transport proteins, the most common among them being the transmembrane P-glycoprotein, a multidrug resistance transporter (ABCB1). Although mammalian information on the structure-function relationship of P-gp has been generated in recent years, we still do not know how it works as an efflux pump or about its role in normal physiology (particularly in teleosts). A role for P-gp certainly exists in altering the pharmacokinetics of natural endogenous compounds and xenobiotics. Still, considerable controversy on its mechanism of action and function in normal cells exists. Through their maintenance, regulation and activity, cellular defense mechanisms such as P-gp can incur energetic costs to an organism. The impact of active xenobiotic cell defense on energy budgets is largely unknown and has been limited to research on biotransformation. This research has several specific aims: 1) to assess the physiological and pharmacological roles of P-gp, 2) begin to elucidate the mechanisms of P-gp and possibly other ABC transporters, 3) increase knowledge of the teleost P-gp substrate base and activities in teleosts, 4) to investigate the relationship between P-gp activity and biotransformation and other xenobiotic/metabolite transporters, and 5) to determine specific energetic costs of P-gp-mediated efflux.
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
121390-2009
Name nom
Kennedy, Christopher
Department département
Biological Sciences
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2009
Award amount
44000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
400
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Environment
Area of application fr
Environnement
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Partie
5
Nb partie
5
Application title
Multixenobiotic resistance mechanisms: function and relevance of P-glycoprotein (ABCB1) in teleosts
Keyword
NSERC
Application summary
One basic cellular strategy underlying resistance to foreign chemicals is to reduce intracellular concentrations. One of the most intriguing defense strategies developed is the activity of the multixenobiotic resistance mechanism (MXR), analogous to the multidrug resistant (MDR) mechanism found in mammalian cell lines and tumors of human patients resistant to chemotherapeutic drugs. MXR activity is mediated by the expression of a variety of transmembrane transport proteins, the most common among them being the transmembrane P-glycoprotein, a multidrug resistance transporter (ABCB1). Although mammalian information on the structure-function relationship of P-gp has been generated in recent years, we still do not know how it works as an efflux pump or about its role in normal physiology (particularly in teleosts). A role for P-gp certainly exists in altering the pharmacokinetics of natural endogenous compounds and xenobiotics. Still, considerable controversy on its mechanism of action and function in normal cells exists. Through their maintenance, regulation and activity, cellular defense mechanisms such as P-gp can incur energetic costs to an organism. The impact of active xenobiotic cell defense on energy budgets is largely unknown and has been limited to research on biotransformation. This research has several specific aims: 1) to assess the physiological and pharmacological roles of P-gp, 2) begin to elucidate the mechanisms of P-gp and possibly other ABC transporters, 3) increase knowledge of the teleost P-gp substrate base and activities in teleosts, 4) to investigate the relationship between P-gp activity and biotransformation and other xenobiotic/metabolite transporters, and 5) to determine specific energetic costs of P-gp-mediated efflux.